Increased level of serum HLA class I antigens in patients with systemic lupus erythematosus. Correlation with disease activity

A. Bresciani, G. Pirozzi, M. Spera, M. L. Lombardi, L. Ambrosone, S. Migliaresi, S. Ferrone, C. Manzo

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The level of soluble β2-μ-associaied HLA Class I heavy chains (sHLA-I) and of soluble β2-μ-free HLA Class I heavy chains (sHLA-FHC) was found to be significantly higher in sera from 58 patients with systemic lupus erythematosus (SLE) than in those from 82 age and sex-matched controls. The level of serum sHLA-I in patients with SLE was significantly correlated to disease activity. Western blotting analysis showed that the 44-kDa isoform represents the major component in the antigens immuno-precipitated by anti-β2-μ mAb NAMB-I and by anti-β2-μ-free HLA Class I heavy chain mAb HC-10 from sera of patients with SLE. These results suggest that the increased serum levels of sHLA-I and of sHLA-FHC in patients with SLE reflect their increased shedding from cell membrane. In view of the ability of sHLA-I and of sHLA-FHC to induce apoptosis of activated T cells, it is suggested that their increased serum levels in patients with SLE is triggered by dysregulation of the immune system leading to T-cell activation. The increased serum levels of sHLA-I and of sHLA-FHC may be used by the immune system to control the pool of activated T cells by inducing apoptosis. If this possibility is proven to be correct, modulation of the serum level of sHLA-I and of sHLA-FHC may be utilized to develop strategies to treat SLE.

Original languageEnglish
Pages (from-to)44-50
Number of pages7
JournalTissue Antigens
Volume52
Issue number1
Publication statusPublished - 1998

Fingerprint

Histocompatibility Antigens Class I
T-cells
HLA Antigens
Systemic Lupus Erythematosus
Immune system
Serum
Apoptosis
Cell membranes
T-Lymphocytes
Protein Isoforms
Chemical activation
Modulation
Immune System
Antigens
Western Blotting
Cell Membrane

Keywords

  • Double determinant immunoassay
  • Serum β-μ-free HLA-I heavy chain
  • Serum HLA-I
  • Systemic lupus erythematosus
  • Western blot

ASJC Scopus subject areas

  • Immunology
  • Cell Biology

Cite this

Bresciani, A., Pirozzi, G., Spera, M., Lombardi, M. L., Ambrosone, L., Migliaresi, S., ... Manzo, C. (1998). Increased level of serum HLA class I antigens in patients with systemic lupus erythematosus. Correlation with disease activity. Tissue Antigens, 52(1), 44-50.

Increased level of serum HLA class I antigens in patients with systemic lupus erythematosus. Correlation with disease activity. / Bresciani, A.; Pirozzi, G.; Spera, M.; Lombardi, M. L.; Ambrosone, L.; Migliaresi, S.; Ferrone, S.; Manzo, C.

In: Tissue Antigens, Vol. 52, No. 1, 1998, p. 44-50.

Research output: Contribution to journalArticle

Bresciani, A, Pirozzi, G, Spera, M, Lombardi, ML, Ambrosone, L, Migliaresi, S, Ferrone, S & Manzo, C 1998, 'Increased level of serum HLA class I antigens in patients with systemic lupus erythematosus. Correlation with disease activity', Tissue Antigens, vol. 52, no. 1, pp. 44-50.
Bresciani A, Pirozzi G, Spera M, Lombardi ML, Ambrosone L, Migliaresi S et al. Increased level of serum HLA class I antigens in patients with systemic lupus erythematosus. Correlation with disease activity. Tissue Antigens. 1998;52(1):44-50.
Bresciani, A. ; Pirozzi, G. ; Spera, M. ; Lombardi, M. L. ; Ambrosone, L. ; Migliaresi, S. ; Ferrone, S. ; Manzo, C. / Increased level of serum HLA class I antigens in patients with systemic lupus erythematosus. Correlation with disease activity. In: Tissue Antigens. 1998 ; Vol. 52, No. 1. pp. 44-50.
@article{57769f4db87b4e5987eaaef75a665049,
title = "Increased level of serum HLA class I antigens in patients with systemic lupus erythematosus. Correlation with disease activity",
abstract = "The level of soluble β2-μ-associaied HLA Class I heavy chains (sHLA-I) and of soluble β2-μ-free HLA Class I heavy chains (sHLA-FHC) was found to be significantly higher in sera from 58 patients with systemic lupus erythematosus (SLE) than in those from 82 age and sex-matched controls. The level of serum sHLA-I in patients with SLE was significantly correlated to disease activity. Western blotting analysis showed that the 44-kDa isoform represents the major component in the antigens immuno-precipitated by anti-β2-μ mAb NAMB-I and by anti-β2-μ-free HLA Class I heavy chain mAb HC-10 from sera of patients with SLE. These results suggest that the increased serum levels of sHLA-I and of sHLA-FHC in patients with SLE reflect their increased shedding from cell membrane. In view of the ability of sHLA-I and of sHLA-FHC to induce apoptosis of activated T cells, it is suggested that their increased serum levels in patients with SLE is triggered by dysregulation of the immune system leading to T-cell activation. The increased serum levels of sHLA-I and of sHLA-FHC may be used by the immune system to control the pool of activated T cells by inducing apoptosis. If this possibility is proven to be correct, modulation of the serum level of sHLA-I and of sHLA-FHC may be utilized to develop strategies to treat SLE.",
keywords = "Double determinant immunoassay, Serum β-μ-free HLA-I heavy chain, Serum HLA-I, Systemic lupus erythematosus, Western blot",
author = "A. Bresciani and G. Pirozzi and M. Spera and Lombardi, {M. L.} and L. Ambrosone and S. Migliaresi and S. Ferrone and C. Manzo",
year = "1998",
language = "English",
volume = "52",
pages = "44--50",
journal = "Tissue Antigens",
issn = "0001-2815",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Increased level of serum HLA class I antigens in patients with systemic lupus erythematosus. Correlation with disease activity

AU - Bresciani, A.

AU - Pirozzi, G.

AU - Spera, M.

AU - Lombardi, M. L.

AU - Ambrosone, L.

AU - Migliaresi, S.

AU - Ferrone, S.

AU - Manzo, C.

PY - 1998

Y1 - 1998

N2 - The level of soluble β2-μ-associaied HLA Class I heavy chains (sHLA-I) and of soluble β2-μ-free HLA Class I heavy chains (sHLA-FHC) was found to be significantly higher in sera from 58 patients with systemic lupus erythematosus (SLE) than in those from 82 age and sex-matched controls. The level of serum sHLA-I in patients with SLE was significantly correlated to disease activity. Western blotting analysis showed that the 44-kDa isoform represents the major component in the antigens immuno-precipitated by anti-β2-μ mAb NAMB-I and by anti-β2-μ-free HLA Class I heavy chain mAb HC-10 from sera of patients with SLE. These results suggest that the increased serum levels of sHLA-I and of sHLA-FHC in patients with SLE reflect their increased shedding from cell membrane. In view of the ability of sHLA-I and of sHLA-FHC to induce apoptosis of activated T cells, it is suggested that their increased serum levels in patients with SLE is triggered by dysregulation of the immune system leading to T-cell activation. The increased serum levels of sHLA-I and of sHLA-FHC may be used by the immune system to control the pool of activated T cells by inducing apoptosis. If this possibility is proven to be correct, modulation of the serum level of sHLA-I and of sHLA-FHC may be utilized to develop strategies to treat SLE.

AB - The level of soluble β2-μ-associaied HLA Class I heavy chains (sHLA-I) and of soluble β2-μ-free HLA Class I heavy chains (sHLA-FHC) was found to be significantly higher in sera from 58 patients with systemic lupus erythematosus (SLE) than in those from 82 age and sex-matched controls. The level of serum sHLA-I in patients with SLE was significantly correlated to disease activity. Western blotting analysis showed that the 44-kDa isoform represents the major component in the antigens immuno-precipitated by anti-β2-μ mAb NAMB-I and by anti-β2-μ-free HLA Class I heavy chain mAb HC-10 from sera of patients with SLE. These results suggest that the increased serum levels of sHLA-I and of sHLA-FHC in patients with SLE reflect their increased shedding from cell membrane. In view of the ability of sHLA-I and of sHLA-FHC to induce apoptosis of activated T cells, it is suggested that their increased serum levels in patients with SLE is triggered by dysregulation of the immune system leading to T-cell activation. The increased serum levels of sHLA-I and of sHLA-FHC may be used by the immune system to control the pool of activated T cells by inducing apoptosis. If this possibility is proven to be correct, modulation of the serum level of sHLA-I and of sHLA-FHC may be utilized to develop strategies to treat SLE.

KW - Double determinant immunoassay

KW - Serum β-μ-free HLA-I heavy chain

KW - Serum HLA-I

KW - Systemic lupus erythematosus

KW - Western blot

UR - http://www.scopus.com/inward/record.url?scp=0031843674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031843674&partnerID=8YFLogxK

M3 - Article

C2 - 9714473

AN - SCOPUS:0031843674

VL - 52

SP - 44

EP - 50

JO - Tissue Antigens

JF - Tissue Antigens

SN - 0001-2815

IS - 1

ER -